Clin2
NCT07761117Possibly a fitRecruiting

Heart failure treatment study for people with preserved pumping function

Heart Failure With Preserved Ejection Fraction (HFpEF)Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)

Treatments studied

Part of Heart & circulation clinical trials.

This study tests an investigational medication called elecoglipron to see if it can improve heart and blood vessel outcomes in people with heart failure with preserved or mildly reduced ejection fraction. If you join, you will receive either the study drug or a placebo, and your heart health will be monitored over time.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
6,950 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have heart failure and are in New York Heart Association class II, III, or IV.
  • Your ejection fraction (a measure of heart pumping strength) is greater than 40%.
  • You have evidence of structural heart disease, like an enlarged heart or thickened heart muscle.
  • Your body mass index (BMI) is 25 or higher.
  • You do not have type 1 diabetes or poorly controlled diabetes (HbA1c below 10%).
  • You have not had certain heart procedures or surgeries in the last 90 days, and you do not have other specific heart conditions.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05441839Recruiting
Heart failure with preserved pumping function study in the UK

This trial studies people who have heart failure symptoms but whose heart pumping strength is largely preserved. It aims to better understand this specific type of heart failure and how best to treat or evaluate it.

Abercynon
NCT06560762Recruiting· Phase 1
Study of a new drug for heart failure with preserved pumping ability

This trial tests an investigational drug for people with a type of heart failure where the heart pumps normally but is stiff. The goal is to see if the drug can improve symptoms and quality of life.

Chicago, Illinois
NCT07493590Not yet recruiting
Heart failure with preserved pumping study

This study looks for people who may have heart failure with preserved pumping function, where the heart is stiff and doesn't fill properly. It aims to better understand and identify this condition to improve care.

Copenhagen
NCT06768437Recruiting
Heart fat and preserved ejection fraction heart failure trial

This study looks at whether fat around the heart affects a type of heart failure where the heart pumps well but is stiff (HFpEF). You may be able to join if you have this condition, are 18 or older, and can understand English.

Leicester, Leicestershire
NCT07642921Not yet recruiting
Understanding heart failure with preserved pumping function through imaging and blood tests

This study looks at people with a type of heart failure where the heart pumps normally but still doesn't fill properly. Researchers are using ultrasound pictures of the heart (echocardiograms) and blood tests to better understand this condition and find better ways to treat it.

NCT06930495Enrolling by invitation
Weight loss and heart failure with normal pumping strength

This study tests whether weight loss treatments can improve muscle and blood vessel function in people with a specific type of heart failure (HFpEF) who also have obesity. It may help if you have heart failure with a normal ejection fraction and a high BMI.

Dallas, Texas

Hear when a new Heart Failure With Preserved Ejection Fraction (HFpEF) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.